跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLMESARTAN/HIDROCLOROTIAZIDA JUBILANT 20 MG/12,5 MG COMPRIMIDOS RECUBIERTOS POR PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OLMESARTAN/HIDROCLOROTIAZIDA JUBILANT 20 MG/12,5 MG COMPRIMIDOS RECUBIERTOS POR PELICULA EFG
Approved
STANDARD
OLMESARTAN/HIDROCLOROTIAZIDA JUBILANT 20 MG/12,5 MG COMPRIMIDOS RECUBIERTOS POR PELICULA EFG
Jubilant Pharmaceuticals
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 8, 2020
Approval ID
85af083ce1bbc866
Company
Jubilant Pharmaceuticals
Type
Standard
Approval Details
Approval Id
85af083ce1bbc866
Drug Cima Aemps Name
OLMESARTAN/HIDROCLOROTIAZIDA JUBILANT 20 MG/12,5 MG COMPRIMIDOS RECUBIERTOS POR PELICULA EFG
Register Number
83640
Holder Company Name
Jubilant Pharmaceuticals
Marketing Company Name
Jubilant Pharmaceuticals
Authorization Date
2020-06-08
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
20 mg/12,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Jubilant Pharmaceuticals
Active Ingredients
OLMESARTAN MEDOXOMILO
20 mg
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 8, 2020
Approval ID
85af083ce1bbc866
Type
Standard
Back to CIMA-AEMPS Approvals